Delayed OTC Markets 5-day change 1st Jan Change
- USD -.--% Intraday chart for ReGen Biologics Inc. -.--% -

Valuation: ReGen Biologics Inc.

Market Cap 1.17M 1.03M 949K 886K 1.67M 111M 1.71M 11.41M 4.41M 54.73M 4.41M 4.31M 190M P/E 2007
-0.9x
P/E 2008 -1.66x
Enterprise Value 11.46M 10.03M 9.26M 8.65M 16.28M 1.08B 16.65M 111M 43.03M 534M 43.03M 42.09M 1.86B EV / Sales 2007
14x
EV / Sales 2008 22.7x
Free-Float
100%
Yield 2007 *
-
Yield 2008 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 25
-1.37%+5.92%-31.60%-13.59% 164B
-0.40%+2.18%-7.08%-6.65% 104B
-1.08%+4.23%-5.70%+48.41% 55.67B
+0.90%-5.29%+52.20%+53.60% 52.92B
-1.48%+9.35%-10.68%-40.94% 42.96B
+2.38%+14.29% - - 32.87B
-0.82%+1.01%-20.07%-45.47% 27.07B
+0.79%+7.18%+61.51%-6.35% 24.79B
-1.41%+6.17%-11.43%-3.72% 21.02B
Average -0.22%+3.43%+3.39%-1.84% 52.49B
Weighted average by Cap. -0.51%+3.98%-6.48%-1.24%

Financials

2007 2008
Net sales 986K 863K 797K 744K 1.4M 93.22M 1.43M 9.59M 3.7M 45.99M 3.7M 3.62M 160M 1.37M 1.2M 1.11M 1.04M 1.95M 130M 2M 13.37M 5.16M 64.09M 5.16M 5.05M 223M
Net income -10.38M -9.09M -8.39M -7.83M -14.74M -981M -15.08M -101M -38.97M -484M -38.97M -38.11M -1.68B -9.95M -8.71M -8.04M -7.51M -14.14M -941M -14.46M -96.8M -37.37M -464M -37.37M -36.55M -1.61B
Net Debt 4.09M 3.58M 3.31M 3.09M 5.82M 387M 5.95M 39.81M 15.37M 191M 15.37M 15.03M 663M 10.28M 9.01M 8.31M 7.76M 14.61M 972M 14.95M 100M 38.62M 480M 38.62M 37.78M 1.67B
Logo ReGen Biologics Inc.
Regen Biologics Inc (ReGen) is a United States-based development stage orthopedic products company. The Company develops, manufactures and markets tissue growth and repair products for United States and global markets. The Company's collagen matrix technology includes applications in orthopedics, general surgery, spine, cardiovascular and drug delivery. Some of these applications are marketable while others are in various stages of development. Its approved product using its collagen matrix technology is the Menaflex collagen meniscus implant device (also known as the CMI), which is marketed for sale in the European Union (EU), Switzerland, Turkey, and the Republic of South Africa, through the Company’s subsidiary, ReGen Biologics AG.
Employees
-
  1. Stock Market
  2. Stocks
  3. RGBOQ Stock